The products to be included in the procurement exercise are: Recombinant factor VIIa, PDFVIII containing vWF concentrate, PDFIX concentrate, PD pure vWF concentrate, PD Factor VIII Inhibitor Bypassing Fraction (FEIBA), PD Factor XIII concentrate, PD Protein C Concentrate, PD Fibrinogen concentrate, Fresh Frozen Plasma, PD FX concentrate, Recombinant Porcine Factor VIII concentrate, Prothrombin Complex Concentrate, Emicizumab (humanised bispecific antibody).
Commercial Medicines Unit - NHS England
2nd Floor, Rutland House
Contract value: 92500000-92500000
Published: 31 Jan 2018, Receipt by: 1 Mar 2018
All suppliers that are registered with us receive email notifications of Public Sector tenders related to their area of business.